Physician profile
Saif Abdulateef
NPI 1285031153
$7,807.03
in general payments reported to CMS, 2019-2025
11 companies · $2,614 in 2025
The $2,614 reported for 2025 was more than what 93% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,090 · 2020: $278 · 2021: $96.41 · 2022: $344 · 2023: $18.21 · 2024: $1,366 · 2025: $2,614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,268 · Food and Beverage: $1,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,268.13 |
| Food and Beverage | $1,730.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $3,814.47 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $1,592.66 | 2019-2021 | |
| Stryker Corporation | $1,313.28 | 2021-2025 | Patient-Fitted Tmj Reconstructive Prosthesis System, Medpor, Vsp System, Vsp Cranial |
| Straumann USA LLC | $396.22 | 2022-2025 | |
| Medical Device Business Services, INC. | $266.91 | 2025 | Trumatch |
| Kls-Martin L.P. | $217.95 | 2024-2025 | |
| Depuy Synthes Sales INC. | $90.07 | 2019 | |
| Zimvie INC. | $64.06 | 2022-2024 | |
| Ss White Burs LLC | $22.31 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $16.30 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saif Abdulateef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.